---
figid: PMC7118423__gr2_lrg
figlink: pmc/articles/PMC7118423/figure/fig0002/
number: Fig. 2
caption: Model of the angiotensin-converting enzyme 2 (ACE2) signalling pathway involved
  in SARS-CoV-induced CCL2 expression. Infection of lung epithelial cells with SARS-CoV
  induces casein kinase II (CK II)-mediated phosphorylation of the ACE2 receptor,
  leading to activation of ERK1/2 and AP-1 and upregulation of CCL2. The elevated
  level of CCL2 protein detected in the sera of SARS-CoV-infected patients may account
  for the development of lung fibrosis. Figure was modified from Chen et al. . SARS-CoV,
  severe acute respiratory syndrome coronavirus; CCL2, chemokine (C-C motif) ligand
  2.
pmcid: PMC7118423
papertitle: 'Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2)
  associated with human respiratory disease: detection, mechanisms and treatment.'
reftext: Shuntong Kang, et al. Int J Antimicrob Agents. 2020 May;55(5):105950-105950.
pmc_ranked_result_index: '19188'
pathway_score: 0.947958
filename: gr2_lrg.jpg
figtitle: The angiotensin-converting enzyme 2 (ACE2) signalling pathway involved in
  SARS-CoV-induced CCL2 expression
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7118423__gr2_lrg.html
  '@type': Dataset
  description: Model of the angiotensin-converting enzyme 2 (ACE2) signalling pathway
    involved in SARS-CoV-induced CCL2 expression. Infection of lung epithelial cells
    with SARS-CoV induces casein kinase II (CK II)-mediated phosphorylation of the
    ACE2 receptor, leading to activation of ERK1/2 and AP-1 and upregulation of CCL2.
    The elevated level of CCL2 protein detected in the sera of SARS-CoV-infected patients
    may account for the development of lung fibrosis. Figure was modified from Chen
    et al. . SARS-CoV, severe acute respiratory syndrome coronavirus; CCL2, chemokine
    (C-C motif) ligand 2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SARS
  - CCL2
  - ACE
  - ACE2
  - NBPF3
  - CSNK2A1
  - CSNK2A2
  - CSNK2B
  - HRAS
  - KRAS
  - NRAS
  - MAPK3
  - MAPK1
  - SARS
  - fibrosis
genes:
- word: SARS
  symbol: SARS
  source: hgnc_symbol
  hgnc_symbol: SARS
  entrez: '6301'
- word: CCL2
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: АСE
  symbol: ACE
  source: hgnc_symbol
  hgnc_symbol: ACE
  entrez: '1636'
- word: АСE2
  symbol: ACE2
  source: hgnc_symbol
  hgnc_symbol: ACE2
  entrez: '59272'
- word: АСE2
  symbol: AE2
  source: hgnc_alias_symbol
  hgnc_symbol: NBPF3
  entrez: '84224'
- word: CKII
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A1
  entrez: '1457'
- word: CKII
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A2
  entrez: '1459'
- word: CKII
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2B
  entrez: '1460'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: CCL2
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK1/2)
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: CCL2
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: CCL2
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
chemicals: []
diseases:
- word: SARS
  source: MESH
  identifier: D045169
- word: fibrosis
  source: MESH
  identifier: D005355
---
